Stem cell research and 3D bioengineered tissues
With scientists and laboratories on three continents, REPROCELL has the scientific and clinical expertise to better translate your discoveries into therapies.
REPROCELL's portfolio includes an extensive product catalog to support stem cell research and 3D bioengineered tissues, a commercial biorepository of ethically-sourced human tissues, extensive clinical networks across the US and Europe that enable our contract research services in human ex vivo living tissues, and our capability to supply induced pluripotent stem cells (iPSCs) for both research and clinical applications.
REPROCELL is also developing novel regenerative medicine therapies to treat neurodegenerative disease, based on its expertise in pluripotent stem cells and mesenchymal stem cells, and is currently conducting clinical trials in Japan for the treatment of spinocerebellar ataxia.
- Stem Cell Reagents
- 3D Cell Culture Systems
- Human Tissue Samples